Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ardent HealthARDT +0.48%39 EV-to-EBIT is 10.48 as of Jul. 23, 2026, which is 7% above its 10-year median of 9.77. GuruFocus rates ARDT with a GF Score™ of 39/100. The stock has 2 warning signs investors should review. Among 468 Healthcare Providers & Services companies, Ardent Health ranks better than 72.44% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ardent Health's Enterprise Value for the quarter that ended in Mar. 2026 was $3,296 Mil.
Ardent Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $340 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ardent Health EV-to-EBIT Related Terms
Ardent Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Ardent Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ardent Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ardent Health EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ardent Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ardent Health's EV-to-EBIT falls into.
Ardent Health's current Enterprise Value is $3,564 Mil.
Ardent Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $340 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ardent Health (ARDT) has a EV-to-EBIT of 10.48 as of Jul. 23, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ardent Health and its competitors. This is near median its historical median of 9.77. Over the past decade, Ardent Health's EV-to-EBIT has ranged from 7.46 to 19.12. According to the industry distribution chart, Ardent Health ranks #129 out of 468 companies in the Healthcare Providers & Services industry, placing it in the top 27.6%.
Is Ardent Health's EV-to-EBIT too high?
Ardent Health's current EV-to-EBIT of 10.48 is near median its 10-year median of 9.77. Over the past 10 years, this metric has ranged from a low of 7.46 to a high of 19.12. The Healthcare Providers & Services industry median EV-to-EBIT is 15.96. Ardent Health's value of 10.48 is 34.3% below this industry median. Based on the distribution chart, Ardent Health ranks #129 out of 468 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ardent Health has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Ardent Health's EV-to-EBIT compare to INNV and AMN?
According to the Healthcare Providers & Services industry distribution chart, Ardent Health ranks #129 out of 468 companies for EV-to-EBIT. This puts Ardent Health in the upper half of its industry. The industry median EV-to-EBIT is 15.96. Ardent Health's value of 10.48 is 34.3% below this benchmark. Historically, Ardent Health's own EV-to-EBIT has ranged from 7.46 to 19.12 over the past decade. While the company's 10-year median is 9.77 vs. the industry median of 15.96, Ardent Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.96, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ardent Health's current EV-to-EBIT of 10.48 is 34.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ardent Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ardent Health's current EV-to-EBIT is 10.48, which is near median its own 10-year median of 9.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ardent Health stock overvalued right now?
Ardent Health (ARDT) has a current EV-to-EBIT of 10.48. The current EV-to-EBIT is 10.48, which is near median its 10-year median of 9.77 and 34.3% below the Healthcare Providers & Services industry median of 15.96. Ardent Health's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Ardent Health (ARDT), the current EV-to-EBIT is 10.48 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S and operating in eight growing mid-sized urban markets across six states Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The main focus on people and investments in services and technologies.
39GF Score
Get the complete analysis for ARDT
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ARDT has been successfully added to your 
